Page 46 - Immunization Practices News Today

The U.S. Food and Drug Administration has authorized emergency use of updated COVID-19 vaccines to target the latest variants of the virus and to protect people against serious illness.

After the Food and Drug Administration signed off on updated COVID-19 vaccines from Moderna and Pfizer on Monday, you may have some questions, including when...

The U.S. Food and Drug Administration (FDA) announced on Monday that it has approved and authorized updated versions of mRNA COVID-19 vaccines for emergency use. The updated vaccines, which are manufactured by Pfizer and Moderna, are "formulated to more closely target currently circulating variants," particularly the Omicron variant XBB.1.5. The vaccines have also been formulated

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and...

By Stacy M. Brown | NNPA - The FDA has approved updated COVID-19 vaccines from Moderna and Pfizer/BioNTech, which are available for administration to individuals 12 and older, with emergency use authorization for individuals six months to 11 years.

If the Centers for Disease Control and Prevention signs off Tuesday, injections could be available in pharmacies, clinics and doctor's offices by the end of the week.

Nirsevimab will be available through the Alaska Immunization Program starting Oct. 1

UPDATED protection against COVID-19 with ModernaTX and Pfizer's updated mRNA vaccines approved by the US FDA for emergency use for 2023-2024.

Updated recommendations from the CDC on the use of pneumococcal vaccines in adults in the United States.

The FDA approved shots for those aged 12 and above, and in emergency for 6 month olds to 11 years